OUTCOME OF THE BOARD MEETING HELD ON 5TH NOVEMBER, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Shri Dinesh Mills Ltd, at its meeting on November 5, 2025, approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from statutory auditors M/s. R. K. Doshi & Co. LLP. The auditor issued an unqualified (clean) review report with no modifications. A key corporate action disclosed is the completed disposal of the company's entire investment in subsidiary Dinesh Remedies Limited (equity and preference shares) on September 3, 2025, following board approval in October 2024. As a result, Dinesh Remedies ceased to be a subsidiary, and the consolidated results include a one-time gain on sale of investments of approximately Rs. 500 lakhs. On a standalone basis, profit before tax for H1 FY26 stood at Rs. 695.44 lakhs versus Rs. 893.61 lakhs in the prior-year period, while consolidated profit before tax improved to Rs. 741.25 lakhs from Rs. 627.45 lakhs. Operating cash flow turned strongly positive compared to a negative figure in the same period last year.
The clean audit and subsidiary divestment are positive for governance clarity, though the standalone profit dip year-on-year is a watchpoint. The gain on the Dinesh Remedies sale is a one-off and should not be extrapolated as recurring earnings. Shareholders should note the shift in consolidated group structure going forward.